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doi:10.1016/j.jfma.2011.03.003Background/Purpose: Intrapulmonary shunting (IPS) due to pulmonary vascular dilatation is
frequently observed among patients with end-stage liver disease (ESLD). This study investi-
gated the prevalence and impact of IPS after liver transplantation (LT) in children.
Methods: A total of 77 pediatric patients who underwent primary LTwere enrolled. All patients
had trans-thoracic contrast echocardiography before LT and at least 1 year after transplanta-
tion. The patients with IPS and without IPS after LT were designated as group 1 and group 2,
respectively.
Results: The prevalence of IPS after LT was 6.1%. The patients in group 1 (nZ 5) were younger
(6.4 þ/- 2.8 vs. 9.9 þ/- 3.6, pZ 0.036) than in group 2 (nZ 72). There were no significant
differences in gender, weight, hemoglobin level, O2 saturation, or complications between
the two groups. Fourteen patients had abnormal liver function tests, two patients in group 1
and 12 patients in group 2 (pZ 0.22).The overall follow-up period was 6.7 þ/- 2.7 years
(range, 1.6e13.0). At the latest follow-up, all 5 patients with mild IPS after LT remain asymp-
tomatic with good liver graft function.lantation Program, Department of Surgery, Chang Gung Memorial Hospital-Kaohsiung Medical Center,
g 833, Taiwan.
.org.tw (C.-L. Chen).
ight ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
316 C.-D. Liang et al.Conclusion: Among pediatric ESLD patients with preoperative IPS, approximately 6% continue
to have mild IPS after LT. Patients with mild IPS after LT remain asymptomatic and have good
liver graft function.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Patients with end stage liver disease (ESLD) are usually in
a life-threatening situation. Liver transplantation (LT) is
indicated in ESLD patients to restore normal physiologic and
hepatic function. The common indications of LT in children
include biliary atresia, chronic hepatitis, fulminant hepa-
titis, chronic hepatic failure, and metabolic disease. Biliary
atresia, a common causes of ESLD, carries a high mortality
rate in infants and children.1,2 Without corrective inter-
vention or LT, the prognosis of these patients is dismal with
reported median survivals of < 2 years.3 After successful
LT, the long-term survival improves with reported 6-month,
1-year, and 5-year survival rates at 99%, 98%, and 98%,
respectively, in a group of biliary atresia patients.4
Intrapulmonary shunting (IPS) due to pulmonary vascular
dilatation is frequently observed among patients with ESLD.
The prevalence is estimated to range from 13% to 47%.5e7
With improvements in surgical and medical care, the
presence of severe IPS, which was historically a relative
contraindication to LT, has become one of the indications
for transplant. To our knowledge, there is no large study to
evaluate IPS after LT in pediatric patients. The aim of this
study was to investigate the prevalence and impact of IPS in
pediatric ESLD patients after LT, utilizing two-dimensional
contrast-enhanced echocardiography.
Patients and methods
From October 1995 to July 2007, 172 pediatric patients (age
< 18 years) underwent primary LT at the Chang Gung
Memorial Hospital-Kaohsiung Medical Center, Taiwan. This
study was approved by the Ethics Committee of Human
Experimentation of Chang Gung Memorial Hospital. A review
of the transplant records was performed. All patients had
two-dimensional trans-thoracic echocardiography evalua-
tion before LT and at least 1 year after transplantation.
Patients who did not undergo contrast-enhanced echocar-
diography, or presented with intra-cardiac shunting, were
excluded. Overseas patients or patients who did not
complete the required follow-up period were also excluded.
Informed consent was obtained from the patients’ parents.
Echocardiography monitoring
The procedure of the echocardiography study had been
published previously.5 The contrast-enhanced echocardi-
ography was performed according to Krowka’s method.6
After connecting two 10 mL syringes to the intravenous
cannula in a 3-way stopcock, another syringe with 5 mL of
saline solution was mixed with 0.2 mL air and connected to
the 3-way stopcock. After agitating the saline solution for10e15 seconds, a forceful hand-injection was applied and
simultaneous two-dimensional echocardiographic evalua-
tion of the heart in an apical four-chamber view was
performed. A simultaneous electrocardiography recording
was also obtained to facilitate detection and timing of
contrast occurrence in the atria. Two injections were
performed in each patient to obtain an optimal contrast
effect in the resting state. Contrast-enhanced echocar-
diograms were analyzed for time delay (in frames)
between the occurrence of microbubbles in the right
atrium and initial occurrence in the left atrium (if
present).
The examination was performed without any sedation.
Contrast-enhanced echocardiography was considered
negative if microbubbles were not observed in the left
atrium. IPS was identified by the initial occurrence of
microbubbles within the left atrium beyond three beats of
opacification of the right atrium, while intra-cardiac
shunting was identified if microbubbles occurred within
three beats. IPS was diagnosed and classified by contrast-
enhanced echocardiography according to Donovan’s
method.8 The opacification of the left atrium by micro-
bubbles was compared with its counterpart in the right
atrium. The degree of IPS was determined by comparing the
amount of microbubbles between the right and left atria
and was defined as mild (LA << RA), moderate (LA < RA),
and severe (LAZ RA) (Fig. 1A, 1B and 1C). The echocardi-
ography images were reviewed jointly by one experienced
pediatric cardiologist and one pediatric radiologist. Any
disagreement was resolved by consensus.
A total of 77 patients were included in this series.
Patients with IPS and without IPS after LT were designated
as group 1 and group 2, respectively. The timing of the post-
transplant data, including age, actual body weight and
weight percentile, serum liver function tests, hemoglobin
level, and room air O2 saturation were taken at the same
day of echocardiography. Differences between the children
who did and those who did not have IPS pre-transplant,
including age and etiology of liver disease, were
compared. Differences between the children whose IPS
regressed after transplantation and those in whom it did
not, were compared; these included age, gender, actual
body weight and weight percentile, serum liver function
tests, hemoglobin level, room air O2 saturation, and
complications of LT. The serum liver function tests which
were monitored pre- and post-transplant, included aspar-
tate aminotransaminase, alanine aminotransaminase, total
bilirubin, albumin, total protein, alkaline phosphatase, and
g-glutamic transaminase. Abnormal liver function was
defined as two episodes of elevation in liver function tests
(AST > 80 U/L and ALT > 80 U/L, or total bilirubin > 2 mg/
dL) occurring 1 year after LT with no identifiable cause.
Complications of LT were defined as any hepatobiliary tract
Figure 1 Contrast echocardiography showing apical four-chamber view. (A) mild IPS; (B) moderate IPS; and (C) severe IPS.
Table 2 Baseline patient characteristics in the two
groups.
Characteristics Group 1
(nZ 5)
Group 2
(nZ 72)
p
Age (y) 6.4 þ/ 2.8 9.9 þ/ 3.6 0.036*
Weight (kg) 23.5 þ/ 11.3 32.0 þ/ 12.5 0.131
Weight percentile 48 þ/ 37 46 þ/ 30 0.869
Gender 4M/1F 37M/35F 0.218
AST (U/L) 82 þ/ 68 55 þ/ 49 0.379
ALT (U/L) 67 þ/ 73 45 þ/ 58 0.562
Bilirubin (mg/dL) 0.8 þ/ 0.3 0.9 þ/ 0.5 0.892
Albumin (g/dL) 4.1 þ/ 0.3 4.2 þ/ 0.3 0.211
TP (g/dL) 7.1 þ/ 0.4 7.3 þ/ 0.7 0.494
ALK-P (U/L) 659 þ/ 784 274 þ/ 154 0.119
Intrapulmonary shunt after liver transplant 317abnormality first seen by abdominal ultrasound and
confirmed by computed tomography or magnetic resonance
imaging after LT and persisted for at least 3 months.
Statistical analysis
Continuous variables were expressed as mean þ/- SD.
Comparison of the parameters between the groups was
performed using the Fisher’s exact test, and Mann-Whitney
U test as appropriate. The statistical procedures were
performed using the Statistics Package for Social Sciences
(SPSS for Windows, Chicago, IL, USA). A p value < 0.05 was
considered statistically significant.
Results
There were 41 boys and 36 girls. Seventy-one patients
underwent living donor LT and six underwent deceased
donor LT. The mean age at the time of LTZ 3.1 þ/- 3.3
years (rangeZ 0.25 to 14.25 years). The etiology of ESLD is
shown in Table 1. Patients with biliary atresia were the
majority (75.3%). Two children had fulminate hepatic
failure that was complicated by acute bacterial
endocarditis.
Among the 77 patients, 18 patients had IPS (14 mild,
3 moderate and 1 severe) and 59 patients had no IPS before
LT. The prevalence of IPS before LT was 23.4% (18/77). In
our previous study, the risk factors for developing IPS
before LT were young age (pZ 0.002) and lower body
weight (pZ 0.002).5 There were no other statistically
significant differences between the two groups.
Analyzing for post-LT IPS, there were five patients in
group 1 and 72 in group 2. The prevalence of IPS after LTTable 1 Etiology of liver transplantation in the 77
patients.
Number (n) Percentage (%)
Biliary atresia 58 75.3
Glycogen storage disease 8 10.4
Chronic hepatic failure 6 7.8
Alagille syndrome 3 3.9
Fulminant hepatic failure 2 2.6
Total 77 100was 6.1%. The etiology of liver disease in the five patients
with post-LT IPS were biliary atresia (nZ 4) and glycogen
storage disease (nZ 1). There were no statistical demo-
graphical differences between the children who did and
those who did not have IPS. The clinical data of the patients
are summarized in Table 2. The patients in group 1 were
younger (6.4 þ/- 2.8 vs. 9.9 þ/- 3.6, pZ 0.036) than in
group 2. There were also no significant differences in terms
of gender, actual body weight and weight percentile,
hemoglobin level, and O2 saturation between the
two groups. Fourteen patients had abnormal liver function
tests; two patients in group 1 and 12 patients in group 2
(pZ 0.22). There were no statistically significant
differences in the levels of aspartate aminotransaminase
(82 þ/- 68 vs. 55 þ/- 49 U/L), alanine aminotransaminase
(67 þ/- 73 vs. 45 þ/- 58 U/L), alkaline phosphatase (659GGT (U/L) 70 þ/ 73 27 þ/ 59 0.217
Hgb (g/dL) 12.5 þ/ 1.1 12.6 þ/ 1.8 0.672
O2 saturation 94.2 þ/ 1.3% 95.1 þ/ 1.5 % 0.675
Surgical
complication
1/5 16/72 0.776
ALK-PZ alkaline phosphatase; ALTZ alanine aminotransa-
minase; ASTZ aspartate aminotransaminase; FZ female;
GGTZ g-glutamic transaminase; HgbZ hemoglobin; MZmale;
TPZ total protein.
Mean values were presented  SD. p values were tested by
Mann-Whitney U and Fisher’s exact tests.
* Z significant difference.
318 C.-D. Liang et al.þ/- 784 vs. 274 þ/- 154 U/L) and g-glutamic transaminase
(70 þ/- 73 vs. 27 þ/- 59 U/L), total bilirubin (0.8 þ/- 0.3 vs.
0.9 þ/- 0.5 mg/dL), albumin (4.1 þ/-0.3 vs. 4.2 þ/-0.3 g/
dL) and total protein (7.1 þ/-0.4 vs. 7.3 þ/-0.7 g/dL)
between groups 1 and 2 (p > 0.05). These data also sug-
gested that abnormal liver function does not correlate with
mild IPS.
There were 17 (22%) post-operative complications in the
entire series. These included portal vein stenosis (nZ 6),
persistent splenomegaly (nZ 5), portal vein stenosis and
persistent splenomegaly (nZ 5), and biliary dilatation
(nZ 1). There was one patient in group 1, and 16 patients
in group 2 (pZ 0.776).
The overall follow-up period was 6.7 þ/-2.7 years
(rangeZ 1.6e13.0 years). Among the 77 patients, 53
patients had a follow-up period of > 5 years, 36 patients of
> 7 years, and 8 patients of > 10 years. At the latest follow-
up, all 5 patients with mild IPS after LT remain asymp-
tomatic with good liver graft function.Discussion
IPS is one of the important etiologies of abnormal pulmo-
nary gas exchange in patients with ESLD.9,10 Several
diagnostic methods have been used to study IPS including A-
aDO2 study, pulmonary angiography, Tc99m-MAA scintig-
raphy, and contrast echocardiography.11 Among these
studies, contrast-enhanced echocardiography has gradually
emerged in clinical settings because of the following
advantages: (1) it can differentiate between intra-
pulmonary and intra-cardiac shunting; (2) it can be used
to evaluate the severity of IPS; (3) it is a convenient choice
because of non-radiation exposure; and (4) it has a higher
sensitivity and specificity than Tc99m-MAA scintigraphy in
making the diagnosis of IPS.12 Further, because it is
extremely sensitive, it can detect small right-to-left shunts
even when systemic arterial saturations are normal.13 We
have used contrast-enhanced echocardiography to evaluate
IPS in ESLD pre-LT in our center for > 10 years. From our
previous experience,5 contrast echocardiography is a very
sensitive and convenient modality to evaluate IPS, espe-
cially in patients with mild to moderate IPS.
The impact of IPS on the quality of life and survival in LT
candidates have been thoroughly investigated,14 and the
resolution of severe IPS after successful LT has also been
reported.15e18 However, there is limited information con-
cerning the prevalence and impact of IPS in pediatric ESLD
patients after LT. The mechanism of IPS in ESLD remains
unclear. Clinical evidence has shown that the prevalence of
IPS decreased after LT.15e17 In the present study, the
prevalence of IPS in pediatric patients after LT was 6.1%.
There are no statistically significant differences between
patients with or without IPS in terms of liver function test
results. However, the long-term effects of IPS in such
patients remain unknown. Further, more cases must be
accrued to eliminate biases related to sample size.
In our previous study, we found that young age and
weight are two risk factors in patients with mild and
moderate IPS before LT.5 After LT, IPS has no correlation
with actual body weight and weight percentile, gender,
serum liver function tests, hemoglobin level, O2 saturation,and complications. Only age is a risk factor for IPS after LT.
There are three possible reasons to explain this. Firstly, IPS
is caused by vasodilation of the pre-capillary vessels and
capillary beds adjacent to the alveoli, resulting in a diffu-
sion-perfusion defect. As crying may aggregate the vaso-
dilation effect, crying at the time of examination may have
caused a biased result. Secondly, IPS may be induced by the
relatively high cardiac output in younger children, as the
blood had less time to diffuse in the alveoli. Thirdly, young
children who experience sudden deterioration of liver
function are a potential contributing factor.
Hepatopulmonary syndrome is a severe form of IPS and
dramatically different from an asymptomatic IPS. In
patients with ESLD, it is still controversial as to whether to
transplant patients with hepatopulmonary syndrome with
severe hypoxemia. However, early IPS is considered an
indication for urgent LT because LT is proven to be a good
treatment option to reverse mild to moderate IPS. Our
results showed that the impact of mild IPS in post-LT
patients was negligible, as there was no statistically
significant difference between groups 1 and 2. This might
be explained by the fact that patients with mild IPS were
characterized by subtle delayed left atrial echogenicity
seen on contrast echocardiography. This suggests that only
a small amount of microbubbles can pass through the lung
during oxygenation. Therefore, there was no significant
deterioration in O2 saturation and the hemodynamic status
remained essentially normal.
In some adult studies of IPS, LT recipients with IPS may
have a greater risk of cardiovascular morbidity and
mortality.19,20 Severe heart failure with low cardiac output
or right-sided heart failure may lead to liver hypo-perfusion
or congestion which may, in turn, cause liver dysfunction.
However, such cardiovascular events are rarely observed in
children. In our series, there was no morbidity or mortality
related to any cardiovascular event during follow-up.
In conclusion, approximately 6% of ESLD children with
preoperative IPS, who undergo LT, continue to have mild
IPS after LT. Patients with mild IPS after LT are asymp-
tomatic and have good liver graft function during follow-up.References
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